Study to Compare the Efficacy & Safety of Ursoplus Capsules vs. UDCA vs. Placebo Among Chronic Liver Disease Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This study aims to compare the efficacy \& safety of Ursoplus® capsules (UDCA 250mg \& Silymarin 140mg) versus UDCA alone versus Placebo among Compensated Chronic Liver Diseased Patients
Epistemonikos ID: 4f96c074ca54744a9ad322029bcc3a753e068703
First added on: Feb 19, 2024